February 18, 2018 2:43 AM ET

Biotechnology

Company Overview of Intrexon Corporation

Company Overview

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and clon...

20374 Seneca Meadows Parkway

Germantown, MD 20876

United States

Founded in 1998

832 Employees

Phone:

301-556-9900

Key Executives for Intrexon Corporation

Chairman and Chief Executive Officer
Age: 64
Chief Financial Officer
Age: 53
Total Annual Compensation: $342.5K
Chief Business Officer
Age: 48
Total Annual Compensation: $500.0K
Compensation as of Fiscal Year 2016.

Intrexon Corporation Key Developments

Intrexon Corporation Seeks Acquisitions

Intrexon Corporation (NYSE:XON) is seeking acquisitions. The company intend to use the net proceeds from the sale of the securities for general corporate purposes and for strategic acquisitions or investments.

Intrexon Corporation Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-10-2018 09:30 AM

Intrexon Corporation Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-10-2018 09:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Randal J. Kirk, Chairman and Chief Executive Officer.

Intrexon Corporation and Third Security, LLC Execute Amendment to the Services Agreement

On December 28, 2017, Intrexon Corporation (Intrexon) and Third Security, LLC (Third Security) executed an amendment (the Third Amendment) to the Services Agreement, dated as of November 1, 2015, and amended on October 31, 2016 and December 30, 2017 (as amended, the Services Agreement), by and between Intrexon and Third Security, in order to extend the term of the Services Agreement from January 1, 2018 to January 1, 2019. No other terms of the Services Agreement were modified by the Third Amendment, which became effective on January 1, 2018. The Third Amendment was unanimously approved by the independent members of Intrexon's Board of Directors and the Audit Committee of the Board in accordance with Intrexon's policy on related person transactions.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 29, 2017
--
Private Placement
October 16, 2017
--
Private Placement
May 10, 2017
Oragenics, Inc.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intrexon Corporation, please visit www.dna.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.